Relmada Therapeutics (RLMD) Non Operating Interest Expenses (2012 - 2015)
Relmada Therapeutics (RLMD) posted quarterly Non Operating Interest Expenses of $723.0 for Q1 2013, up 133.98% quarter-over-quarter from $309.0 in Q4 2012.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Non Operating Interest Expenses (2012 - 2015) Analysis & Trends
Relmada Therapeutics (RLMD) has reported Non Operating Interest Expenses for 2 consecutive years, with $723.0 the latest figure, recorded in Q1 2013.
- In Q1 2013, Non Operating Interest Expenses changed N/A year-over-year to $723.0; the TTM figure through Aug 2013 stood at $1032.0 (changed N/A YoY), while the FY2013 annual figure was $1032.0, down 78.17% from the prior year.
- Non Operating Interest Expenses improved to $723.0 in Q1 2013 per RLMD's latest filing, from $309.0 in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $2589.0 in Q2 2012 and bottomed at $309.0 in Q4 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -1.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 23.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 39.74 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 82.05 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 93.62 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Relmada Therapeutics | 498.39 Mn | 498.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 1,172.00 |
| Sep 30, 2015 | 1,642.00 |
| Jun 30, 2015 | 431.00 |
| Mar 31, 2015 | 125.00 |
| Dec 31, 2014 | 1,098.00 |
| Sep 30, 2014 | 3,268.00 |
| Jun 30, 2014 | 435,611.00 |
| Mar 31, 2014 | 302,440.00 |
| Feb 28, 2013 | 723.00 |
| Nov 30, 2012 | 309.00 |
| Aug 31, 2012 | 1,048.00 |
| May 31, 2012 | 2,589.00 |